{"log_id": 5425701917062941545, "direction": 0, "words_result_num": 32, "words_result": [{"probability": {"variance": 0.000285, "average": 0.981419, "min": 0.948275}, "location": {"width": 117, "top": 223, "height": 25, "left": 411}, "words": "给药推迟一周"}, {"probability": {"variance": 0.000706, "average": 0.970808, "min": 0.929553}, "location": {"width": 111, "top": 227, "height": 27, "left": 628}, "words": "给药推迟一周"}, {"probability": {"variance": 0.039265, "average": 0.682822, "min": 0.390885}, "location": {"width": 66, "top": 233, "height": 21, "left": 839}, "words": "止治疗"}, {"probability": {"variance": 0.038844, "average": 0.674441, "min": 0.361313}, "location": {"width": 175, "top": 252, "height": 27, "left": 217}, "words": "活受造内肠道"}, {"probability": {"variance": 0, "average": 0.997599, "min": 0.997599}, "location": {"width": 25, "top": 254, "height": 24, "left": 1125}, "words": "局"}, {"probability": {"variance": 0.000444, "average": 0.989456, "min": 0.91029}, "location": {"width": 784, "top": 374, "height": 47, "left": 223}, "words": "出现血液毒性的剂量调整白细胞减少症是这一人群出现最多的不良反应,嗜中性粒"}, {"probability": {"variance": 0.051698, "average": 0.860439, "min": 0.354179}, "location": {"width": 410, "top": 424, "height": 38, "left": 177}, "words": "减少疝、贫血和血小板减少症也有出现"}, {"probability": {"variance": 0.019218, "average": 0.927622, "min": 0.503138}, "location": {"width": 739, "top": 475, "height": 45, "left": 222}, "words": "当病人ANC计数<1.0/m3和/或血小板计数<500/m3时需要临时暂停本品"}, {"probability": {"variance": 0.015466, "average": 0.929961, "min": 0.558045}, "location": {"width": 756, "top": 525, "height": 46, "left": 244}, "words": "ANC计数<1.0/m3时,可在随后的治疗中同时给予粒细胞集落刺激因子(G-CsF"}, {"probability": {"variance": 0.005793, "average": 0.952658, "min": 0.76629}, "location": {"width": 332, "top": 572, "height": 38, "left": 201}, "words": "GM-CSF)治疗,以维持血细胞数量"}, {"probability": {"variance": 3.9e-05, "average": 0.99563, "min": 0.984913}, "location": {"width": 86, "top": 624, "height": 27, "left": 218}, "words": "特殊病人"}, {"probability": {"variance": 0.020641, "average": 0.95016, "min": 0.383379}, "location": {"width": 601, "top": 669, "height": 45, "left": 170}, "words": "功能不全病人:曾对少量肝功能不全病人(胆红素值达4mg/dl"}, {"probability": {"variance": 0.072945, "average": 0.772785, "min": 0.392639}, "location": {"width": 90, "top": 661, "height": 55, "left": 852}, "words": "医药"}, {"probability": {"variance": 0.019595, "average": 0.930488, "min": 0.446571}, "location": {"width": 565, "top": 722, "height": 45, "left": 336}, "words": "浆清除率和清除半衰期未见变化。根据以往使用益多柔上星"}, {"probability": {"variance": 0.020465, "average": 0.935598, "min": 0.476704}, "location": {"width": 560, "top": 772, "height": 42, "left": 337}, "words": "丁肝功能不全的病人应减少给药量。建议当胆红素高以数"}, {"probability": {"variance": 0.023775, "average": 0.88822, "min": 0.401994}, "location": {"width": 645, "top": 823, "height": 42, "left": 334}, "words": "少用:血清胆红索1230mgl,采用常用量的12:于30mgr时"}, {"probability": {"variance": 5e-05, "average": 0.992683, "min": 0.980323}, "location": {"width": 166, "top": 871, "height": 28, "left": 334}, "words": "采用常用量的14"}, {"probability": {"variance": 0.008971, "average": 0.955349, "min": 0.600714}, "location": {"width": 815, "top": 916, "height": 45, "left": 170}, "words": "行能不全病人:由于多柔比星虫肝脏代谢和经胆汁排泄,故使用本品时剂不需要调整"}, {"probability": {"variance": 0.009319, "average": 0.957216, "min": 0.638802}, "location": {"width": 620, "top": 963, "height": 44, "left": 163}, "words": "除病人:日前尚无本品用于脾切除病人的经验,故不推荐使用"}, {"probability": {"variance": 8e-06, "average": 0.998414, "min": 0.991943}, "location": {"width": 119, "top": 1013, "height": 29, "left": 168}, "words": "【不良反应】"}, {"probability": {"variance": 0.007962, "average": 0.96808, "min": 0.581511}, "location": {"width": 534, "top": 1062, "height": 41, "left": 206}, "words": "以下引国外上市的盐酸多柔比星脂质体的临床文献资料"}, {"probability": {"variance": 0.008557, "average": 0.963163, "min": 0.488406}, "location": {"width": 786, "top": 1110, "height": 47, "left": 207}, "words": "对ADS-KS病人进行的临床开放和对照研究显示,与盐酸多柔比星脂质体相关的最常见"}, {"probability": {"variance": 0.014429, "average": 0.966608, "min": 0.444695}, "location": {"width": 430, "top": 1156, "height": 40, "left": 157}, "words": "的不良反应是骨髓抑制,儿乎近一半病人发生"}, {"probability": {"variance": 0.005084, "average": 0.982407, "min": 0.57079}, "location": {"width": 781, "top": 1206, "height": 47, "left": 208}, "words": "广胞减少是病人最常见的不良反应,也可见贫血和血小板减少。这些反应一般在治"}, {"probability": {"variance": 0.00538, "average": 0.965023, "min": 0.688084}, "location": {"width": 832, "top": 1254, "height": 47, "left": 156}, "words": "早期使可见,但仅是暂时性的。临床试验中很少有因严重骨髓抑制而停药的事件发生。在"}, {"probability": {"variance": 0.012112, "average": 0.95844, "min": 0.565068}, "location": {"width": 676, "top": 1302, "height": 45, "left": 156}, "words": "出现血液学梅性反应时,应按“出现血液毒性的剂量调整”方法进行处理"}, {"probability": {"variance": 0.039446, "average": 0.751122, "min": 0.55251}, "location": {"width": 115, "top": 1314, "height": 44, "left": 904}, "words": "山办"}, {"probability": {"variance": 0.025567, "average": 0.930691, "min": 0.350494}, "location": {"width": 784, "top": 1352, "height": 45, "left": 203}, "words": "自临床研究使用盐酸多柔比星脂质体过程中,出现的较常见的有临床意义的实验检"}, {"probability": {"variance": 0.014209, "average": 0.957824, "min": 0.380084}, "location": {"width": 790, "top": 1399, "height": 46, "left": 153}, "words": "查异常(≥5%),还包括碱性磷酸酶升高以及天冬酰胺转移酶和胆红素升高,些检"}, {"probability": {"variance": 0.006212, "average": 0.967575, "min": 0.659553}, "location": {"width": 830, "top": 1444, "height": 50, "left": 150}, "words": "常被认为与基础病有关,而与盐酸多柔比星脂质体无关。根据报道,在使用盐多柔比"}, {"probability": {"variance": 0.016355, "average": 0.932111, "min": 0.419797}, "location": {"width": 787, "top": 1492, "height": 47, "left": 149}, "words": "背质体的过程,血红蛋白血小板减少的发生率较低(<5%),白细胞减少导致的脓"}, {"probability": {"variance": 0.013288, "average": 0.956633, "min": 0.468707}, "location": {"width": 833, "top": 1540, "height": 48, "left": 146}, "words": "更为少(<1%):上述某些检测指标异常的产生可能与HIV感染有关,而非盐酸多柔"}], "language": 3}